Financials

  • Market Capitalization 930.64 M
  • Employee 239
  • Founded 2021
  • CEO N/A
  • Website www.alumis.com
  • Headquarter Delaware, United States
  • FIGI BBG01J7X4PN2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.41
Relación precio/flujo de caja
34.51

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2424
KURA
Kura Oncology, Inc. - Common Stock
10.45 USD-1.42%-1.14%-8.09%+5.24%929.64 M USD
2429
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
49.12 USD+0.08%+1.66%+3.80%+63.03%917.55 M USD
2432
MLTX
MoonLake Immunotherapeutics - Class A Ordinary Shares
10.87 USD+0.46%-6.70%-13.46%+13.70%925.11 M USD
2436
JBIO
Jade Biosciences, Inc. - Common Stock
14.39 USD+1.70%-0.35%-20.32%+43.18%915.17 M USD